<DOC>
	<DOCNO>NCT00143156</DOCNO>
	<brief_summary>To evaluate efficacy safety pregabalin administer twice day compare placebo reduce pain subject painful diabetic peripheral neuropathy .</brief_summary>
	<brief_title>Pregabalin v Placebo Treatment Neuropathic Pain Associated With Diabetic Peripheral Neuropathy</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Males female least 18 year age , ethnic origin Type 1 2 diabetes mellitus Pain score great equal 4 11point numeric pain rating scale Neurologic disorder unrelated diabetic neuropathy may confuse confound assessment neuropathic pain . Presence severe pain associated condition diabetic peripheral neuropathy , could confound assessment selfevaluation pain due DPN .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>